Moreover, miR‐589‐5p mimic and inhibitor reversed the effects of METTL3 silencing and overexpression on liver cancer, indicating that METTL3/miR‐589‐5p enhanced the malignant development of liver cancer. Here, METTL3 is linked to liver cancer.